Cargando…
Research-based PAM50 signature and long-term breast cancer survival
PURPOSE: Multi-gene signatures provide biological insight and risk stratification in breast cancer. Intrinsic molecular subtypes defined by mRNA expression of 50 genes (PAM50) are prognostic in hormone-receptor positive postmenopausal breast cancer. Yet, for 25–40% in the PAM50 intermediate risk gro...
Autores principales: | Pu, Minya, Messer, Karen, Davies, Sherri R., Vickery, Tammi L., Pittman, Emily, Parker, Barbara A., Ellis, Matthew J., Flatt, Shirley W., Marinac, Catherine R., Nelson, Sandahl H., Mardis, Elaine R., Pierce, John P., Natarajan, Loki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985186/ https://www.ncbi.nlm.nih.gov/pubmed/31542876 http://dx.doi.org/10.1007/s10549-019-05446-y |
Ejemplares similares
-
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
por: Wallden, Brett, et al.
Publicado: (2015) -
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
por: Hurson, Amber N., et al.
Publicado: (2023) -
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
por: Liu, Minetta C, et al.
Publicado: (2016) -
Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women
por: Rosner, Bernard, et al.
Publicado: (2015) -
A comparative study of PCS and PAM50 prostate cancer classification schemes
por: Yoon, Junhee, et al.
Publicado: (2021)